LIOTHYRONINE MARKET ANALYSIS

Liothyronine MarketSize and Trends

Increasing prevalence of thyroid related conditions owing to factors such as unhealthy diet, and modified life style has increased in the thyroid conditions such as hypothyroidism. For instance, according to the National Institute of Health 2019 report, hypothyroidism affects around 5% of individuals worldwide each year. Therefore, pharmaceutical companies are focusing on advancement in the field of treatment of thyroid related conditions, which is expected to drive growth of global liothyronine market. For instance, in 2019, Titan Pharmaceuticals, Inc. presented the clinical data on efficiency of 'ProNeura', a sub-dermal implant, characterized with properties such as sustain release dosage form in treatment of hypothyroidism. These factors are expected to drive the global liothyronine market over the forecast period.